Protech Home Medical Announces Date and Time for Q4 And full Year Fiscal 2020 Conference Call and Audio Webcast
Protech Home Medical Corp. (OTCQX: PTQQF) will host its Q4 and Full Year Fiscal 2020 earnings conference call on February 2, 2021, at 4:00 p.m. (EST). The call aims to discuss financial performance and growth strategies in the home medical equipment sector, focusing on respiratory care. Protech Home Medical provides in-home monitoring and disease management services, with a goal to expand offerings for chronic conditions. The company seeks to enhance shareholder value by increasing revenue per patient through integrating multiple services.
- Focus on expanding services for chronic conditions can lead to increased revenue.
- Organic growth strategy aims to consolidate patient services, improving customer experience.
- None.
CINCINNATI, Feb. 01, 2021 (GLOBE NEWSWIRE) -- Protech Home Medical Corp. (the “Company”) (TSXV: PTQ) (OTCQX: PTQQF), a U.S. based leader in the home medical equipment industry, focused on end-to-end respiratory care, today announced that it will host its Q4 and Full Year Fiscal 2020 earnings conference call and audio webcast on Tuesday, February 2, 2021 at 4:00 p.m. (EST).
Conference Call Details:
Tuesday, February 2, 2021 at 4:00 p.m. (EST).
Canada/US Toll Free: 1 (800) 319 4610
International: 1 (604) 638 5340
Audio Webcast Details:
The live audio webcast can be found on the investor section of the Company’s website through the following link:
https://protechhomemedical.com/conference_calls
ABOUT PROTECH HOME MEDICAL
The Company provides in-home monitoring and disease management services including end-to-end respiratory solutions for patients in the United States healthcare market. It seeks to continue to expand its offerings to include the management of several chronic disease states focusing on patients with heart or pulmonary disease, sleep disorders, reduced mobility and other chronic health conditions. The primary business objective of the Company is to create shareholder value by offering a broader range of services to patients in need of in-home monitoring and chronic disease management. The Company’s organic growth strategy is to increase annual revenue per patient by offering multiple services to the same patient, consolidating the patient’s services and making life easier for the patient.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
For further information please visit our website at www.protechhomemedical.com, or contact:
Cole Stevens
VP of Corporate Development
Protech Home Medical Corp.
859-300-6455
cole.stevens@myphm.com
Gregory Crawford
Chief Executive Officer
Protech Home Medical Corp.
859-300-6455
investorinfo@myphm.com
FAQ
When will Protech Home Medical announce its Q4 earnings?
What is the stock symbol for Protech Home Medical?
What services does Protech Home Medical provide?
